Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.
| Excerpt | Reference |
|---|
| "Ulcerative colitis is a disease confined to the colon in an age from 20 to 40 years mainly." | ( Flechsig, U; Richter, P; Seidel, H, 1989) |
| "A child with ulcerative colitis is described in whom many unusual complications of the disease occurred." | ( Moore, TL; Speiser, JC; Zuckner, J, 1985) |
| "Ulcerative colitis is not associated with a higher spontaneous abortion rate than the general population, although it is not clear whether certain subgroups of patients have a higher rate of abortion." | ( Spiro, HM; Vender, RJ, 1982) |
| "Ulcerative colitis is distinguished by abundant prostaglandin E2 (PGE 2) in the stools and by severe diarrhea." | ( Mah, MY; Rood, RP; Sernka, TJ; Tseng, CH, 1982) |
| "Ulcerative colitis is associated with many ocular complications." | ( Burgess, JA; Goy, JA; Lazell, RW; Tesar, PJ, 1981) |
| "Since ulcerative colitis is primarily a mucosal disease, total colectomy with rectal mucosectomy and ileo-endomuscular pull-through (Soave) offers many theoretical advantages." | ( Andrews, HG; Caplan, DB; Zwiren, GT, 1981) |
| "Ulcerative colitis is one of the few diseases in which smoking appears to confer some benefit (1)." | ( Lewis, RA; Watson, JP, 1995) |
| "Ulcerative colitis is frequently associated with extraintestinal inflammatory manifestations." | ( Fretz, C; Hoffman, M; Knoblauch, A; Rickli, H; Walser, A, 1994) |
| "Ulcerative colitis is largely a disease of nonsmokers." | ( Feyerabend, C; Mani, V; Newcombe, RG; Rhodes, J; Russell, MA; Thomas, GA; Williams, GT, 1995) |
| "Ulcerative colitis is a rare disease in young infants." | ( Hoppen, T; Keller, KM; Rister, M; Stolte, M, 1993) |
| "Ulcerative colitis is largely a disease of nonsmokers." | ( Feyerabend, C; Ganesh, S; Mani, V; Morris, JS; Newcombe, RG; Pullan, RD; Rhodes, J; Russell, MA; Thomas, GA; Williams, GT, 1994) |
| "Ulcerative colitis is an illness that occurs unexpectedly in a young patient, with a generally unpredictable prognosis, and there is no medication to cure it." | ( Bigard, MA, 1993) |
| "Ulcerative colitis is a chronic inflammatory disease and the most common form of inflammatory bowel disease, which is a debilitating and unpredictable group of illnesses affecting the gastrointestinal tracts of over 2 million Americans." | ( Claussen, DW, 1993) |
| "The hallmark of ulcerative colitis is a diffuse infiltration of neutrophils from the circulation into the colonic mucosa." | ( Haydek, JM; Keshavarzian, A, 1995) |
| "Ulcerative colitis is a chronic inflammatory disease of the colon that affects the rectum and a variable length of contiguous colon." | ( Das, KM; Griffel, LH, 1996) |
| "Ulcerative colitis is largely a disease of non-smokers." | ( Feyerabend, C; Mani, V; Newcombe, RG; Ragunath, K; Rhodes, J; Russell, MA; Thomas, GA; Williams, GT, 1996) |
| "Ulcerative colitis is a chronic inflammatory disease of the colon where leukotrienes are suggested to play an important role for keeping inflammation active." | ( Ammon, HP; Gupta, I; Lüdtke, R; Malhotra, P; Parihar, A; Safayhi, H; Singh, GB, 1997) |
| "Ulcerative colitis is predominantly a disease of nonsmokers." | ( Batts, KP; Croghan, IT; Dale, LC; Hurt, RD; Lawson, GM; Offord, KP; Petersen, BT; Sandborn, WJ; Schroeder, DR; Tremaine, WJ, 1997) |
| "Ulcerative colitis is largely a disease of nonsmokers, and transdermal nicotine is of therapeutic value in the active disease." | ( Evans, BK; Feyerabend, C; Fuller, GS; Green, JT; Newcombe, RG; Rhodes, J; Russell, MA; Sandborn, WJ; Thomas, GA, 1997) |
| "Ulcerative colitis is associated with abnormalities of mucin synthesis and secretion, features that may also be associated with malignant change." | ( Corfield, AP; Jones, CJ; Mayberry, JF; McMahon, RF; Probert, CS; Stoddart, RW; Warren, BF, 1997) |
| "Ulcerative colitis is predominantly a disease of non-smokers, and transdermal nicotine is therapeutic but often results in side-effects." | ( Batts, KP; Compton, RF; Green, J; Hurt, RD; Lawson, GM; Leighton, JA; Lipsky, JJ; Mays, DC; Offord, KP; Sandborn, WJ; Tremaine, WJ; Zins, BJ, 1997) |
| "Ulcerative colitis is associated with a selective reduction of n-butyrate oxidation by the colonic epithelial cells although the reason for this has been unclear." | ( Babidge, WJ; Millard, SH; Moore, JW; Roediger, WE, 1997) |
| "Refractory ulcerative colitis is best treated surgically." | ( Kam, L, 1998) |
| "Ulcerative colitis is a chronic inflammatory condition characterized by an altered intestinal immunoinflammatory response." | ( Amorosi, A; Calabrò, A; Garcea, MR; Mantellini, P; Paladini, I; Panerai, C; Renzi, D; Salvadori, G; Surrenti, C, 1998) |
| "Ulcerative colitis is predominantly a disease of non-smokers, and transdermal nicotine has therapeutic benefit but causes frequent side-effects." | ( Evans, BK; Feyerabend, C; Green, JT; Rhodes, J; Russell, MA; Sandborn, WJ; Thomas, GA, 1998) |
| "Ulcerative colitis is a nonspecific inflammatory disease of large intestine." | ( Asakura, H, 1998) |
| "Ulcerative colitis is a chronic inflammatory disease state of unknown etiology." | ( Frazee, LA; Slyk, MP, 1997) |
| "Ulcerative colitis is predominantly a disease of nonsmokers and transdermal nicotine has therapeutic value in active disease; however side-effects are troublesome." | ( Evans, BK; Feyerabend, C; Green, JT; Ranshaw, C; Rhodes, J; Russell, MA; Thomas, GA, 1999) |
| "Ulcerative colitis is a condition of nonsmokers in which nicotine is of therapeutic benefit." | ( Green, JT; Marshall, RW; McKirdy, HC; Rhodes, J; Richardson, C; Thomas, GA; Williams, GT, 2000) |
| "Diarrhea in ulcerative colitis is therefore related, at least in part, to a major defect in electrogenic Na+ absorption, which reflects changes in the levels of expression of critical subunits of both the apical Na+ channel and basolateral Na(+)-K(+)-ATPase." | ( Greig, E; Sandle, GI, 2000) |
| "Ulcerative colitis is an inflammatory bowel disease with chronic diarrhea, rectal bleeding and characteristic histological findings." | ( Ala-Mello, S; Kääriäinen, H; Koskimies, O, 2001) |
| "Ulcerative colitis is managed mainly in secondary care by regular outpatient reviews done by specialist clinicians." | ( Roberts, C; Robinson, A; Thompson, DG; Wilkin, D, 2001) |
| "Ulcerative colitis is a chronic inflammatory bowel disorder of unknown etiology." | ( Alexandrowitz, A; Arber, N; Brazowski, E; Dotan, I; Hallak, A; Halpern, Z; Hershkoviz, R; Knaani, Y; Santo, M, 2001) |
| "Ulcerative colitis is characterized by dysfunctional motility." | ( Hussein, SM; Khan, I; Oriowo, M, 2002) |
| "Crohn's disease and ulcerative colitis are characterized by recurrent inflammatory involvement of different intestinal segments involving distinctive urinary patterns." | ( Castelnuovo, C; Lizzano, R; Pisani, E; Trinchieri, A; Zanetti, G, 2002) |
| "Severe ulcerative colitis is conventionally treated with parenteral corticosteroids followed by oral corticosteroids." | ( Awasthi, G; Midha, V; Sood, A; Sood, N, 2002) |
| "Patients with ulcerative colitis are at risk for colon cancer and frequently have microsatellite instability,which, in turn, is usually associated with inactivation of transforming growth factor (TGF) beta signaling." | ( Balish, E; Boivin, GP; Croft, J; Doetschman, T; Engle, SJ; Ormsby, I; Pawlowski, S, 2002) |
| "Crohn's disease and ulcerative colitis are the most frequent inflammatory bowel diseases (IBD) with a prevalence of approximately one out of 500." | ( Göke, B; Ochsenkühn, T; Sackmann, M, 2003) |
| "Ulcerative colitis is a chronic inflammatory disease of the colon of unknown cause." | ( Kane, SV; Tuvlin, JA, 2003) |
| "Ulcerative colitis is a chronic inflammatory bowel disease." | ( Kullak-Ublick, GA; Rammert, Ch, 2003) |
| "In humans, ulcerative colitis is normally treated with aminosalicylates (ASAs) and corticosteroids (CSs) to reduce inflammation." | ( Brubaker, PL; L'Heureux, MC, 2003) |
| "Steroid refractory ulcerative colitis is most commonly treated with intravenous ciclosporin to avoid colectomy." | ( Hinterleitner, TA; Högenauer, C; Petritsch, W; Wenzl, HH, 2003) |
| "In the early stages ulcerative colitis is reversible and a normal bowel can be regained." | ( JONES, FA, 1955) |
| "Patients with ulcerative colitis are at increased risk of colorectal cancer." | ( Forbes, A; Kamm, M; Price, A; Rumbles, S; Rutter, M; Saunders, B; Schofield, G; Talbot, I; Wilkinson, K; Williams, C, 2004) |
| "Severe ulcerative colitis is potentially life threatening even though a policy of intensive medical management and early colectomy in recent years reduced mortality to almost zero." | ( Daperno, M; Ercole, E; Pera, A; Rigazio, C; Rocca, R; Scaglione, N; Sostegni, R, 2004) |
| "Ulcerative colitis is characterized by chronic inflammation of the colon." | ( Fölsch, UR; Kühbacher, T; Schreiber, S, 2004) |
| "Left-sided ulcerative colitis is not a distinct entity, but a less extensive form of pancolitis." | ( Haghighi, DB; Lashner, BA, 2004) |
| "Ulcerative colitis is an inflammatory bowel disease often associated with extra-intestinal manifestations, such as dermatological disorders." | ( Amantea, A; Consolazio, A; Crispino, P; Di Palma, V; Iacopini, F; Paoluzi, OA; Paoluzi, P; Pica, R; Rivera, M, 2004) |
| "Ulcerative colitis is largely a disease of nonsmokers." | ( Macdonald, JK; McDonald, JW; McGrath, J, 2004) |
| "Ulcerative colitis is associated with altered contractile activity and transit time of colon." | ( Al Moutaery, A, 2005) |
| "Ulcerative colitis is a common inflammatory bowel disease (IBD) of unknown etiology." | ( Arafah, M; El-Medany, A; Mahgoub, A; Moursi, M; Mustafa, A, 2005) |
| "Patients with ulcerative colitis are at greater risk of developing colorectal cancer than the general population." | ( Biasco, G; Di Marco, MC, 2005) |
| "Ulcerative colitis is a chronic relapsing or chronic active disease which starts at the rectum and presents with a continuous inflammation." | ( Siegmund, B; Zeitz, M, 2005) |
| "Ulcerative colitis is a chronic inflammatory and debilitating disease requiring lifelong treatment." | ( Kane, SV, 2006) |
| "Ulcerative colitis is a frequent chronic inflammatory boxel disease." | ( Chemli, S; Hammami, W; Jebali, A; Rym, D, 2006) |
| "Ulcerative colitis is associated with elevated tHcy concentration, particularly in the active stage, and in more recurrent types of the disease; this elevation does not seem to be prevented by a normal folate status and might have an enhancing effect on the procoagulation blood profile." | ( Bald, E; Czupryniak, L; Drzewoski, J; Gasiorowska, A; Małecka-Panas, E, 2006) |
| "Relapse of ulcerative colitis is difficult to predict by routine colonoscopy." | ( Ando, T; Goto, H; Ishiguro, K; Kusugami, K; Maeda, O; Nishio, Y; Niwa, Y; Ohmiya, N; Watanabe, O, 2006) |
| "Ulcerative colitis is a chronically recurrent inflammatory bowel disease of unknown origin." | ( Arafa, M; El-Eter, E; El-Medany, A; Hagar, HH, 2007) |
| "Severe ulcerative colitis is therefore considered a medical emergency, the management of which requires close collaboration between gastroenterologists and surgeons." | ( Caprilli, R; Latella, G; Viscido, A, 2007) |
| "Ulcerative colitis is characterised by impairment of the epithelial barrier and tight junction alterations resulting in increased intestinal permeability." | ( Heavey, PM; McGilligan, VE; Ridley, DL; Rowland, IR; Wallace, JM, 2007) |
| "Ulcerative colitis is a chronic inflammatory disease of the gastrointestinal tract." | ( Bardini, KC; Benetton, CA; Cardoso, VH; Dal-Pizzol, F; Damiani, CR; Di Giunta, G; Pinho, RA; Stoffel, C; Streck, EL, 2007) |
| "Crohn's disease and ulcerative colitis are two idiopathic inflammatory bowel disorders." | ( Baumgart, DC; Sandborn, WJ, 2007) |
| "Ulcerative colitis is characterized by relapsing mucosal inflammation where the lesions include tissue-damaging granulocytes." | ( Bjartell, A; Carlson, M; Egesten, A; Eliasson, M; Erjefält, JS; Olin, AI; Sangfelt, P, 2007) |
| "Ulcerative colitis is a chronic inflammatory disease of the colon and rectum." | ( Abbasoğlu, SD; Barbaros, U; Erbil, Y; Giriş, M; Necefli, A; Olgaç, V; Toker, GA; Yanik, BT, 2007) |
| "Ulcerative colitis is a chronic inflammatory bowel disease." | ( Chande, N; MacDonald, JK; McDonald, JW, 2007) |
| "Ulcerative colitis is a chronic disease with recurrent symptoms and significant morbidity." | ( Gotsch, PB; Krafczyk, MA; Langan, RC; Skillinge, DD, 2007) |
| "Ulcerative colitis is an inflammatory bowel disease of uncertain etiology with recurrent symptoms and considerable morbidity." | ( Dalal, L, 2007) |
| "Severe ulcerative colitis is a potentially life-threatening condition." | ( Aratari, A; Caprilli, R; Capurso, L; Clemente, V; Koch, M; Luchetti, R; Moretti, A; Papi, C, 2008) |
| "The aetiology of ulcerative colitis is uncertain but may relate to environmental factors in genetically predisposed individuals." | ( Coffey, JC; Docherty, NG; O'Connell, PR; Rowan, FE, 2009) |
| "Patients with ulcerative colitis are at increased risk for developing colorectal cancer." | ( Abreu, MT; Breglio, K; Chen, A; Cohen, J; Conduah, D; Fukata, M; Goo, T; Hernandez, Y; Hsu, D; Xu, R, 2009) |
| "Ulcerative colitis is also in complete remission stage." | ( Baba, HA; Gerken, G; Kahraman, A; Maldonado-Lopez, E; Miller, M; Treichel, U, 2009) |
| "Patients with ulcerative colitis are at risk for colorectal cancer (CRC)." | ( Bryant, SC; Garrity-Park, MM; Loftus, EV; Sandborn, WJ; Smyrk, TC, 2009) |
| "Crohn's disease and ulcerative colitis are chronic inflammatory disease of the intestine,which frequently require surgery for complications or failure of medical therapy." | ( Bosques-Padilla, FJ; Galindo-Marines, SL; Yamamoto-Farusho, JK, 2008) |
| "Ulcerative colitis is a chronic relapsing and remitting inflammatory disorder that can generally be managed successfully with maintenance oral medications." | ( Cheifetz, AS; Doherty, GA, 2009) |
| "Ulcerative colitis is an intractable inflammatory colonic disease, and its etiology remains unclear." | ( Fujiwara, K; Kadowaki, M; Kageyama-Yahara, N; Kuramoto, H; Shimada, Y; Watanabe, T; Yamamoto, T; Yoshida, M, 2010) |
| "Ulcerative colitis is a nonspecific inflammatory disorder characterized by oxidative and nitrosative stress, leucocyte infiltration and upregulation of inflammatory mediators." | ( Cárdeno, A; de la Lastra, CA; Sánchez-Fidalgo, S; Talero, E; Villegas, I, 2010) |
| "Ulcerative colitis is an autoimmune-inflammatory disease characterized by abnormally increased expression of Toll-like receptor-4 (TLR4) in colonic epithelial cells, increased production of pro-inflammatory cytokines (e." | ( Benavides, U; Dagia, NM; Deosarkar, SP; Goetz, DJ; Gonzalez-Murguiondo, M; Harii, N; Kohn, LD; Kurjiaka, DT; Lewis, CJ; Sakhalkar, HS, 2010) |
| "Ulcerative colitis is a chronically recurrent inflammatory bowel disease of unknown origin." | ( Hassan, GS; Soliman, GA, 2010) |
| "Ulcerative colitis is a chronic condition that requires long-term treatment." | ( Bernick, SJ; Kane, S, 2010) |
| "Crohn's disease and ulcerative colitis are clinically, immunologically, and morphologically distinct forms of inflammatory bowel disease (IBD)." | ( Sarna, SK; Shi, XZ; Winston, JH, 2011) |
| "Acute severe ulcerative colitis is a potentially lethal condition that requires a pro-active approach with either effective medical treatment or timely colectomy." | ( Rutgeerts, P; Van Assche, G; Vermeire, S, 2011) |
| "Ulcerative colitis is presenting with increasing severity and extent in recent times." | ( Ray, G, 2011) |
| "Acute severe ulcerative colitis is a serious condition that requires early hospitalization, with intensive monitoring and treatment." | ( Avellini, C; Fabro, M; Fiorino, G; Sorrentino, D; Szabo, H; Tabuso, M; Terrosu, G, 2011) |
| "Ulcerative colitis is a nonspecific inflammatory disorder characterized by oxidative and nitrosative stress, leucocyte infiltration and up-regulation of pro-inflammatory cytokines." | ( He, J; Liang, J; Sun, W; Zhang, Y; Zhao, W; Zhu, S, 2011) |
| "Ulcerative colitis is a chronic inflammatory condition associated with a high colon cancer risk." | ( Chumanevich, A; Chumanevich, AA; Davis, T; Hofseth, AB; Hofseth, LJ; Le, PM; Nagarkatti, M; Nagarkatti, PS; Poudyal, D; Wargovich, MJ; Windust, A, 2012) |
| "Crohn's disease and ulcerative colitis are inflammatory bowel diseases characterised by a chronic relapsing course." | ( Aratari, A; Chiesara, F; Doddato, MT; Fascì Spurio, F; Margagnoni, G; Papi, C, 2012) |
| "Ulcerative colitis is a chronic inflammatory disease of the colon for which current treatments are not universally effective." | ( Ghosh, S; Niezychowski, W; Panes, J; Rousell, S; Sandborn, WJ; Su, C; Vranic, I, 2012) |
| "Ulcerative colitis is an idiopathic, chronic inflammatory disorder of the colonic mucosa, which starts in the rectum and generally extends proximally in a continuous manner through part of, or the entire, colon; however, some patients with proctitis or left-sided colitis might have a caecal patch of inflammation." | ( Baumgart, DC; Eckmann, L; Ordás, I; Sandborn, WJ; Talamini, M, 2012) |
| "Ulcerative colitis is less prevalent in smokers." | ( Leong, RW; Lunney, PC, 2012) |
| "Ulcerative colitis is far more common than Crohn's disease in our setting." | ( Adkar, S; Jain, AK; Jain, M; Sircar, S; Waghmare, C, 2012) |
| "Crohn's disease and ulcerative colitis are highly related genetically." | ( Abreu, MT; Strobel, S, 2013) |
| "Ulcerative colitis is a chronic recurrent disease characterized by acute inflammation of the colonic mucosa." | ( Fukushima, T; Hamasaki, A; Harada, N; Hayashi, T; Inagaki, N; Joo, E; Matsunaga, T; Muraoka, A; Nasteska, D; Shide, K; Suzuki, K; Tsuda, K; Tsuji, H; Yamane, S, 2013) |
| "Ulcerative colitis is an inflammatory bowel disease, clinical presentation is not specific and may mimic Crohn's disease, radiation colitis, ischemic colitis, a variety of infectious processes, and colitis related to medications." | ( Azak, A; Duranay, M; Huddam, B; Kiliç, F; Koçak, E; Koçak, G, 2012) |
| "The treatment of ulcerative colitis is based on systemic corticosteroids, immunomodulators such as cyclosporine and azathioprine and TNF-α antagonists." | ( Hartmann, F; Stein, J; Tannich, E, 2013) |
| "Ulcerative colitis is a chronic inflammatory disease and involves multiple etiological factors." | ( Chen, X; Ding, B; Hou, Y; Liu, Y; Long, M; Wang, L; Wang, Q; Wu, G; Yi, D, 2013) |
| "Ulcerative colitis is a chronic inflammatory disorder characterized by oxidative stress, leucocyte infiltration and upregulation of pro-inflammatory cytokines." | ( Guruvayoorappan, C; Sakthivel, KM, 2013) |
| "Ulcerative colitis is a chronic inflammatory disease of the colon of unknown cause that is characterized by alternating intervals of active and inactive disease in 80-90% of patients." | ( Blonski, W; Buchner, AM; Lichtenstein, GR, 2014) |
| "Ulcerative colitis is an inflammatory disease that involves only the colon and rectum, being characterized by leukocyte infiltrate and superficial ulcers in the intestinal mucosa." | ( Fillmann, HS; Hartmann, RM; Marroni, NP; Martins, MI; Meurer, L, 2014) |
| "Ulcerative colitis is an inflammatory bowel disease characterized by acute inflammation, ulceration, and bleeding of the colonic mucosa." | ( Tun, X; Yamada, K; Yasukawa, K, 2014) |
| "Ulcerative colitis is associated with an alteration in gonadal hormones and affects testicular weight in rodents." | ( Jena, GB; Parmar, AR; Trivedi, PP, 2014) |
| "Ulcerative colitis is a chronic idiopathic inflammatory bowel disease characterized by continuous mucosal inflammation that starts in the rectum and extends proximally." | ( Cheifetz, AS; Feuerstein, JD, 2014) |
| "Crohn's disease and ulcerative colitis are chronic inflammatory conditions affecting the gut and can present at any age with increased numbers of diagnoses seen in many countries in recent years." | ( Day, AS; Ledder, O; Lemberg, DA, 2015) |
| "Ulcerative colitis is a chronic inflammatory bowel disease." | ( Ahmed, MA; El Morsy, EM; Kamel, R, 2015) |
| "Ulcerative colitis is a chronic inflammatory condition in which the inflammatory response confined to the colon." | ( Bijjem, KR; Goyal, N; Kumar, P; Rana, A, 2015) |
| "Ulcerative colitis is a chronic disease having a regressive nature." | ( El-Kawy, OA; Farah, K; Ibrahim, IT, 2015) |
| "Ulcerative colitis is an inflammatory disorder characterized by neutrophils infiltration, oxidative stress, upregulation of pro-inflammatory mediators and cytokines." | ( He, Z; Li, W; Mu, Q; Niu, X; Wang, X; Wang, Y; Yao, H; Zhang, H, 2015) |
| "Ulcerative colitis is associated with a considerable reduction in the quality of life of patients." | ( Kumar, JM; Kuncha, M; Medicherla, K; Sahu, BD; Sistla, R; Sudhakar, G, 2015) |
| "Ulcerative colitis is a major inflammatory bowel disease (IBD), characterized by inflammation within the gastrointestinal tract through chronic or relapsing immune system activation." | ( Chen, Y; Lin, Q; Liu, B; Luo, F; Shi, L; Yang, T; Zeng, L, 2015) |
| "The patient of ulcerative colitis is increasing every year and it is anticipated that the patient with mesalazine-induced pneumonia may also increase." | ( Abe, T; Akiyama, N; Matsui, T; Nozue, T; Suda, T; Yokomura, K, 2015) |
| "Ulcerative colitis is a chronic nonspecific inflammatory disease of unknown cause." | ( He, J; Huo, C; Li, J; Lv, L; Sun, W; Suo, Y; Wang, J; Wang, Z; Yang, Y; Zhang, Y; Zheng, Z, 2016) |
| "Ulcerative colitis is an immunologic disorder of the intestine which involves the mucosa and sometimes the submucosa." | ( Biedermann, L; D'cunja, J; Roose, L, 2016) |
| "Ulcerative colitis is a lifelong, immunologically mediated disease." | ( Arai, M; Haga, Y; Kanda, T; Katsuno, T; Nakamoto, S; Nakamura, M; Ohta, Y; Sasaki, R; Wu, S; Yasui, S; Yokosuka, O, 2016) |
| "Treatment of active ulcerative colitis is associated with incomplete efficacy, adverse events, and loss of response." | ( Adar, T; Chowers, Y; Dotan, I; Fich, A; Goldin, E; Israeli, E; Levy-Nissenbaum, E; Shteingart, S; Soreq, H, 2016) |
| "Ulcerative colitis is a common chronic inflammatory disease of the colon and rectum, resulting from a dysregulated immune response towards intraluminal antigens in a genetically predisposed host." | ( D'Haens, G; Hindryckx, P; Jairath, V, 2016) |
| "Ulcerative colitis is a chronic inflammatory disease affecting the colon and is characterized by epithelial damage and barrier dysfunction." | ( Balendran, CA; Böttcher, G; Eckersley, S; Henderson, N; Hughes, G; Nyström, AC; Price, SA; Randall, K; Reens, J; South, MC, 2016) |
| "The main symptom of ulcerative colitis is diarrhoea, which is often accompanied by painful tenesmus and faecal blood and mucus." | ( Guzek, D; Głąbska, D; Lech, G; Włodarek, D; Zakrzewska, P, 2016) |
| "Ulcerative colitis is a chronic inflammatory disease affecting the colon, and its incidence is rising worldwide." | ( Allen, PB; Colombel, JF; Mehandru, S; Peyrin-Biroulet, L; Ungaro, R, 2017) |
| "Ulcerative colitis is a relapsing inflammatory disorder of the colon." | ( Ghasemi-Pirbaluti, M; Hosseini, MJ; Motaghi, E; Najafi, A, 2017) |
| "Ulcerative colitis is majorly associated with oxidative stress and inflammation in colon tissue leading to damage." | ( Berlin Grace, VM; Guruvayoorappan, C; Sakthivel, KM; Suluvoy, JK, 2017) |
| "Crohn's disease and ulcerative colitis are the two major types of inflammatory bowel disease, and affect mainly the gastrointestinal tract but also have extraintestinal sequelae, such as arterial and venous thromboembolism." | ( Jang, S; Kang, SB; Kim, SH; Park, JK; Park, Y; Sung, Y; Yun, J, 2017) |
| "Ulcerative colitis is one of the most common types of inflammatory bowel disease and is multifactorial and relapsing." | ( Gao, YF; Ma, N; Sun, LL; Zhang, F; Zhang, JG, 2017) |
| "Ulcerative colitis is a well-known inflammatory bowel disease." | ( Abe, H; Fujita, Y; Ishida, N; Ishioka, M; Nakajima, Y; Ohnishi, S; Sato, A; Shichiri, M; Suzuki, S; Umeno, A; Yasunaga, M; Yoshida, Y, 2018) |
| "Ulcerative colitis is a chronic and recurrent inflammatory disease involving the intestine." | ( Dong, W; Liu, Z; Tian, S; Zhou, K, 2018) |
| "Ulcerative colitis is a type of chronic inflammation present in the intestines for which the aetiology is not yet clear." | ( Dou, J; Fan, H; Fang, K; Gu, Y; Mao, K; Wang, H; Wang, Y; Zhou, C, 2018) |
| "Ulcerative colitis is characterized by colonic mucosal bleeding and ulceration, often with repeated active and remission stages." | ( Tun, X; Yamada, KI; Yasukawa, K, 2018) |
| "Acute severe ulcerative colitis is a life-threatening medical emergency, which can be associated with significant morbidity and is preventable through prompt and effective management." | ( Ahuja, V; Jain, S; Limdi, JK, 2019) |
| "Ulcerative colitis is a chronic inflammatory bowel disease with high incidence and prevalence worldwide." | ( Ariakia, F; Avan, A; Bahreyni, A; Behnam-Rassouli, R; Hashemzehi, M; Hassanian, SM; Khazaei, M; Moradi Marjaneh, R; Pashirzad, M; Rahmani, F; Rezaei, N; Ryzhikov, M; Shafiee, M, 2020) |
| "BACKGROUND Ulcerative colitis is a chronic, idiopathic inflammatory disease that destroys the colon structure." | ( Du, B; Liu, B; Lu, Y; Shi, Y; Sun, M; Zhou, Y, 2019) |
| "Background Ulcerative colitis is a chronic mucosal inflammation of the large intestine mainly affecting the colon and rectum." | ( Bali, A; Jaggi, AS; Kaur, G; Walia, D, 2019) |
| "Ulcerative colitis is a chronic inflammatory disorder characterized by oxidative stress and upregulation of proinflammatory mediators in colonic tissue." | ( Amirshahrokhi, K, 2019) |
| "Ulcerative colitis is a chronic auto-inflammatory disorder confined to the colorectal region." | ( Abu-Risha, SE; Amer, MS; El-Mahdy, NA; Saleh, DA, 2020) |
| "Ulcerative colitis is an inflammatory bowel disease that affects the mucous membrane of the colon." | ( Barros, SÉL; Bráz, DC; da Silva, AS; de Moura, MSB; de Pinho, FA; Lima, MM; Marreiro, DDN; Nogueira, NDN; Parente, JML; Silva, TMC; Soares, NRM; Vieira, EC, 2020) |
| "Acute severe ulcerative colitis is a high stakes event with significant numbers still requiring emergent colectomy, representing a need to establish alternative medical management options." | ( Kotwani, P; Lewin, S; Terdiman, J, 2020) |
| "Ulcerative Colitis is a universal autoimmune disease with high incidence rates worldwide." | ( Arafa, EA; Mohamed, WR; Omar, HA; Zaher, DM, 2020) |
| "Ulcerative colitis is an inflammatory condition affecting the colon, with an annual incidence of approximately 10 to 20 per 100,000 people." | ( Akobeng, AK; Baines, PA; Gordon, M; Iheozor-Ejiofor, Z; Kaur, L; Sinopoulou, V, 2020) |
| "Ulcerative colitis is an inflammatory condition affecting the colon, with an annual incidence of approximately 10 to 20 per 100,000 people." | ( Akobeng, AK; Baines, PA; Gordon, M; Iheozor-Ejiofor, Z; Kaur, L; Sinopoulou, V, 2020) |
| "Ulcerative colitis is a chronic inflammatory disease involving the colon and rectum." | ( Choi, S; Coburn, ES; Holubar, SD; Levy, LC, 2020) |
| "Ulcerative colitis is a chronic mucosal inflammatory condition that adversely affects colon and rectum." | ( Ahmad, A; Khan, R; Kumar, A; Mishra, RK; Raza, SS; Vyawahare, A, 2020) |
| "Ulcerative colitis is an incurable condition whereby patients are at an increased risk of developing colorectal cancer (CRC)." | ( Chartier, LC; Howarth, GS; Mashtoub, S; Trinder, D, 2021) |
| "Ulcerative colitis is one of the IBD which cause a chronic intestinal inflammation and dysfunctional of the mucosal barrier." | ( Cai, C; Chen, Q; Jin, S; Li, N; Yang, B; Zhao, D, 2020) |
| "Ulcerative colitis is a common intestinal inflammatory disease." | ( Luo, M; Luo, Y, 2021) |
| "Crohn's and ulcerative colitis are common inflammatory conditions associated with Inflammatory bowel disease." | ( Bhadada, SK; Bhatia, R; Bishnoi, M; Kaur, J; Khare, P; Kondepudi, KK; Rajarammohan, S; Sharma, S; Sharma, SS; Singh, S, 2020) |
| "Ulcerative colitis is a chronic inflammatory bowel disease with an estimated 150 000 patients in Germany alone." | ( Dignass, A; Kannengiesser, K; Koletzko, S; Kucharzik, T, 2020) |
| "Ulcerative colitis is a chronic gastrointestinal disease characterized by intestinal inflammation and serious mucosal damage." | ( Li, D; Qian, B; Ren, Y; Song, JL; Wang, C; Zeng, Z, 2020) |
| "Ulcerative colitis is common types of severe, progressive, idiopathic inflammatory bowel disease that involves the mucosal lining of the large intestine." | ( Ingawale, DK; Mandlik, SK; Patel, SS, 2021) |
| "Ulcerative colitis is a gut inflammatory disorder due to altered immune response to gut microbiome, with interplay of environmental and genetic factors." | ( Abdallah, HM; El-Halawany, AM; Murad, HAS; Rafeeq, M, 2021) |
| "Ulcerative colitis is an autoimmune inflammatory disorder with a negative impact on the life quality of patients." | ( Abdelaleem, EA; Elhennawy, MG; Mohamed, WR; Zaki, AA, 2021) |
| "Acute severe ulcerative colitis is a medical emergency that warrants in-patient management." | ( Rosiou, K; Selinger, CP, 2021) |
| "Patients with ulcerative colitis are typically suspected of an inflammatory flare based on suggestive symptoms of inflammation." | ( Chen, J; Chen, JDZ; Chen, Y; Gharibani, P; Guo, Y; Selaru, FM, 2021) |
| "Ulcerative colitis is a chronic inflammatory condition of the gastrointestinal tract that can affect people of worldwide." | ( Alesci, A; Cutroneo, G; Favaloro, A; Lauriano, ER; Melita, G; Pallio, S; Pergolizzi, S; Rizzo, G, 2021) |
| "Ulcerative colitis is a form of inflammatory bowel disease that is characterized by acute and chronic inflammation." | ( Fokam Tagne, MA; Kamgang, R; Kom, B; Mazo, AG; Ngakou Mukam, J; Noubissi, PA; Sokeng Dongmo, S; Tchoffo, A, 2021) |
| "Ulcerative colitis is a subtype of inflammatory bowel disease, characterized by relapsing inflammation in the gastrointestinal tract with limited treatment options." | ( Chen, SG; Kwok, HF; Lau, CB; Lee, JK; Li, XX; Shaw, PC; Simmonds, MSJ; Yue, GG; Zheng, T, 2021) |
| "Ulcerative colitis is a common non-specific chronic disease." | ( Li, S; Xiao, D; Yin, Y; Zou, Y, 2021) |
| "Ulcerative colitis is an inflammatory bowel disease that forms ulcerations in the mucous membrane of the colon and rectum, in which gut microbiota plays a pivotal role in its pathogenesis." | ( Aljofan, M; Babenko, D; Chulenbayeva, L; Gulyayev, A; Kozhakhmetov, S; Kozhakhmetova, S; Kushugulova, A; Muhanbetganov, N; Nurgaziyev, M; Nurgozhina, A; Sergazy, S; Tuyakova, A, 2022) |
| "Ulcerative colitis is a recurrent inflammatory illness of the colon with an elevated risk of developing colon cancer." | ( Bettadaiah, BK; Mathew, NS; Muthukumar, SP; Negi, PS, 2022) |
| "Ulcerative colitis is the most prevalent forms of inflammatory bowel diseases and a refractory autoimmune disease and affects millions of people worldwide." | ( Ouyang, J; Sun, L; Wu, S; Zeng, F, 2022) |
| "Ulcerative colitis is a chronic inflammatory bowel disease." | ( Juillerat, P; Laharie, D; Nachury, M; Pellet, G; Roblin, X; Veyrard, P, 2023) |
| "Ulcerative colitis is a complex inflammatory bowel disorder disease that can induce rectal and colonic dysfunction." | ( Kim, HW; Kim, JS; Lee, BS; Lee, JW; Lee, SK; Lee, YI; Park, HW; Whang, J; Yoon, HS; Yu, AR, 2022) |
| "Ulcerative colitis is a chronic inflammatory bowel disease involving a dysregulated immune response in the intestinal mucosa." | ( Paik, J, 2022) |
| "Ulcerative colitis is an idiopathic disease that is widely incident worldwide." | ( Abdelhamid, AM; Amin, NA; Cavalu, S; El-Ahwany, E; El-Azez, RA; El-Rafi, AA; El-Sandarosy, R; Elagamy, HI; Essam, M; Essam, N; Gaafar, AGA; Girgis, S; Hasaballah, A; Kamal, I; Mahmoud, F; Mansour, M; Mohamed, D; Mohammed, OA; Nasr, M; Rizk, H; Saber, S; Youssef, ME, 2022) |
| "Crohn's disease and ulcerative colitis are the two main forms of IBD." | ( Abdalkareem Jasim, S; Hosseini-Fard, SR; Jawad, MA; Kamal Abdelbasset, W; Karampoor, S; Mahmudiono, T; Mirzaei, R; Mohammad, HJ; Rudiansyah, M; S Azizov, B; Samusenkov, V; Yasin, G, 2022) |
| "Ulcerative colitis is a unique inflammatory bowel disease with ulcerative lesions of the colonic mucosa." | ( He, Y; Ma, X; Shen, J; Wang, Y; Zhang, Y; Zhong, T, 2022) |
| "Ulcerative colitis is an inflammatory bowel disease characterized by symptoms such as abdominal pain, diarrhea, bleeding, and weight loss." | ( Kim, SK; Park, SY; Yeom, JE, 2022) |
| "Ulcerative colitis is an inflammatory bowel disease characterized by symptoms such as abdominal pain, diarrhea, bleeding, and weight loss." | ( Kim, SK; Park, SY; Yeom, JE, 2022) |
| "Ulcerative colitis is an inflammatory bowel disease characterized by symptoms such as abdominal pain, diarrhea, bleeding, and weight loss." | ( Kim, SK; Park, SY; Yeom, JE, 2022) |
| "Ulcerative colitis is a multifactorial disease of the gastrointestinal tract which is caused due to chronic inflammation in the colon; it usually starts from the lower end of the colon and may spread to other portions of the large intestine, if left unmanaged." | ( Ahmad, A; Khan, R; Kumar, A; Mishra, RK; Nadeem, A; Raza, SS; Sakla, R; Siddiqui, N; Vyawahare, A, 2023) |
| "Ulcerative colitis is a multifactorial disease of the gastrointestinal tract which is caused due to chronic inflammation in the colon; it usually starts from the lower end of the colon and may spread to other portions of the large intestine, if left unmanaged." | ( Ahmad, A; Khan, R; Kumar, A; Mishra, RK; Nadeem, A; Raza, SS; Sakla, R; Siddiqui, N; Vyawahare, A, 2023) |
| "Ulcerative colitis is a chronic inflammatory bowel disorder that is hard to cure once diagnosed." | ( Chen, H; Jiang, R; Lian, Q; Sha, W; Tu, S; Wu, H; Yang, Q; Zeng, R; Zhuo, Z, 2022) |
| "Ulcerative colitis is a type of inflammatory bowel disease responsible for the inflammation of the innermost lining of the colon and rectum." | ( Cheng, H; Wang, Q; Yin, Z, 2023) |
| "Ulcerative colitis is a condition of chronic inflammation affecting the large intestine." | ( Basnet, BK; Bhandari, A, 2022) |
| "Ulcerative colitis is a chronic inflammatory bowel disease caused by the body's inability to control its immune system." | ( Peyrin-Biroulet, L; Wils, P, 2023) |
| "Ulcerative colitis is an inflammatory condition with ulcerations throughout the colon." | ( Baranauskaite, J; Özdemir, S; Sümer, E; Üner, B; Yaba, A; Yıldırım, E, 2023) |
| "Ulcerative colitis is an inflammatory bowel disease (IBD) with relapsing and remitting patterns, and it is caused by varied factors, such as the intestinal inflammation extent and duration." | ( Jeon, SM; Kim, HH; Kim, K; Kim, KY; Kim, YJ; Shin, CS; Song, YH; Yoon, JW, 2023) |
| "Pediatric ulcerative colitis is likely to be more severe than adult ulcerative colitis." | ( Fukura, S; Ichihara, Y; Kondo, S; Mori, K; Ono, A; Shichijo, K; Suzuki, Y; Takei, M; Takeuchi, S; Tayama, T, 2023) |
| "Ulcerative colitis is characterized by colonic inflammation." | ( Howarth, GS; Mashtoub, S, 2023) |
| "Ulcerative colitis is characterized as a chronic immune-mediated inflammatory condition, affecting the intestinal gastroenteric tissue." | ( Bhatt, LK; Parihar, N, 2023) |
| "Ulcerative colitis is an inflammation-related disease with a high recurrence risk." | ( Jiao, X; Liu, C; Wang, R; Wang, Z; Zhang, C; Zhang, J, 2023) |
| "Ulcerative colitis is a chronic inflammation of the colon." | ( Amini-Khoei, H; AnjomShoa, M; Ghasemi-Dehnoo, M; Lorigooini, Z; Rafieian-Kopaei, M, 2023) |
| "Ulcerative colitis is a lifelong inflammatory disease affecting the rectum and colon to a variable extent." | ( Honap, S; Le Berre, C; Peyrin-Biroulet, L, 2023) |
| "Ulcerative colitis is a relapsing and remitting disease that may be associated with flares." | ( Dutta, U; Jearth, V; Mahajan, G; Patil, AN; Rana, VS; Saroch, A; Sekar, A; Sharma, V; Singh, AK; Singh, H, 2023) |
| "Ulcerative colitis is a chronic inflammatory disease with high mortality and morbidity worldwide." | ( Abu-Raghif, A; Jaafar, FR, 2023) |
| Excerpt | Reference |
|---|
| "The modern medical and surgical treatment of ulcerative colitis has been detailed." | ( Watkinson, G, 1976) |
| "Intal was applied intrarectally for the treatment of ulcerative colitis in 39 patients with active pathological process." | ( Chachaj, W; Kuczymska-Sekieta, K; Malolepszy, J, 1977) |
| "In 51 untreated cases of ulcerative colitis and Crohn's disease some cellular (neutrophil alkaline phosphatase activity, neutrophil NBT reducing capacity, and neutrophil and plasma lysozyme activities) and humoral (serum orosomucoid and serum haptoglobin) indices of disease activity were quantitated." | ( Klitgaard, NA; Koldkjaer, O; Schmidt, KG, 1978) |
| "A new paradigm for the treatment of ulcerative colitis has recently been presented: Treatment of the mucosa with lidocaine (2%) enemas for prolonged periods." | ( Ahlman, H; Björck, S; Dahlström, A; Johansson, L, 1992) |
| "Azathioprine maintenance treatment in ulcerative colitis is beneficial for at least two years if patients have achieved remission while taking the drug." | ( Axon, AT; Foster, PN; Hawkey, CJ; Hawthorne, AB; Lennard-Jones, JE; Logan, RF; Scott, BB; Swarbrick, ET, 1992) |
| "During successful treatment of active ulcerative colitis normalization of serum retinol levels without substitution of vitamin A was observed." | ( Bartnik, W; Butruk, E; Janczewska, I; Kazik, E; Ostrowski, J; Tomecki, R, 1991) |
| "Basis treatment of severe ulcerative colitis and Crohn's disease comprises the systemic administration of corticosteroids." | ( Kreisel, W; Rasenack, J, 1991) |
| "The efficacy of various drugs used to treat ulcerative colitis, (sulfasalazine, 5-aminosalicylate, hydrocortisone) was investigated in a model of acetic acid-induced colitis in the rat." | ( Bostwick, JS; Decktor, DL; Fitzpatrick, LR; Pendleton, RG; Renzetti, M, 1990) |
| "It is concluded that in the topical treatment of ulcerative colitis, BDP may be preferable to PP because it exerts a promising anti-inflammatory action without affecting adrenocortical function." | ( Endert, E; Houthoff, HJ; Mulder, CJ; Tytgat, GN; van der Heide, H; Wiersinga, W; Wiltink, EH, 1989) |
| "It is concluded that, in the topical treatment of ulcerative colitis, BDP is preferable to BMT because it exerts an equal anti-inflammatory action without affecting adrenocortical function." | ( Bansky, G; Buchmann, P; Bühler, H; Häcki, WH; Müller, J; Stamm, B, 1987) |
| "It is concluded that maintenance treatment of ulcerative colitis with sulphasalazine should be continued indefinitely unless contraindicated by side effects." | ( Dissanayake, AS; Truelove, SC, 1973) |
| "A survey of 458 patients treated for ulcerative colitis either medically or surgically by colectomy and the establishment of an ileostomy has provided further evidence that in Australia at least there is a significant association between ulcerative colitis and urinary calculi." | ( Bennett, RC; Hughes, ES, 1972) |
| "Initial treatment of ulcerative colitis generally includes corticosteroids administered either rectally, orally, or parenterally." | ( Jacknowitz, AI, 1980) |
| "The present state of the art in medical treatment of ulcerative colitis is reviewed in the light of lifelong clinical experience with this disease." | ( Truelove, SC, 1981) |
| "The drug is useful in the treatment of active ulcerative colitis as well as in preventing relapses of the disease in remission." | ( Peppercorn, MA, 1984) |
| "Sulphasalazine treatment in ulcerative colitis causes only minor disturbance to the populations of bacteria colonizing the colorectal mucosa." | ( Gent, AE; Grace, RH; Hartley, MG; Hellier, MD; Hudson, MJ; Swarbrick, ET, 1996) |
| "Glucocorticoids are an effective treatment of ulcerative colitis." | ( Andus, T; Caesar, I; Gross, V; Hohenberger, W; Roth, M; Schölmerich, J, 1997) |
| "Effective medical treatment of ulcerative colitis is available." | ( Schölmerich, J, 1997) |
| "Aminosalicylates are widely used in the treatment of ulcerative colitis (UC)." | ( Gibson, JA; Green, JR; Hodgson, HJ; Holdsworth, CD; Kerr, GD; Leicester, RJ; Lobo, AJ; Parkins, KJ; Taylor, MD, 1998) |
| "Topical therapy for the treatment of ulcerative colitis is also discussed." | ( Ragnarsson, G; Ulmius, J; Wikberg, M, 1997) |
| "The role of alternative drugs for the treatment of distal ulcerative colitis and its different forms is reviewed." | ( Ardizzone, S; Bianchi Porro, G, 1998) |
| "A 54-year-old woman who had been treated for ulcerative colitis for 7 years had severe hypoproteinemia." | ( Kawabe, J; Kuroki, T; Matsumoto, T; Moriyama, Y; Ochi, H; Okuyama, C; Oshitani, N; Shiomi, S, 1998) |
| "Drugs for the treatment of ulcerative colitis are sulphapyridine, 5-aminosalicylic acid, prednisolone, betamethasone and immunosuppressive drugs." | ( Asakura, H, 1998) |
| "Addition of a 6-month ciprofloxacin treatment for ulcerative colitis improved the results of conventional therapy with mesalamine and prednisone." | ( Färkkilä, MA; Hakala, K; Miettinen, TA; Ogren, M; Seppälä, K; Sivonen, A; Turunen, UM; Valtonen, VV; Vuoristo, M, 1998) |
| "Selection of treatment for ulcerative colitis is based on the definition of clinical severity." | ( Fujinuma, S; Nakajima, S; Sakai, K; Sakai, Y, 1999) |
| "These results suggest that medical treatment of ulcerative colitis must aim for maintenance of appropriate NO levels in the intestinal mucosa." | ( Hokari, R; Itoh, K; Iwai, A; Kato, S; Kobayashi, M; Koyama, H; Miura, S; Miyahara, T; Tanaka, M; Yoshida, Y, 2000) |
| "It can be concluded that treatment of ulcerative colitis by the integrated method is superior to that by simple western drugs." | ( Chen, Q; Zhang, H, 1999) |
| "The role of antibiotics in the treatment of ulcerative colitis is controversial." | ( Amberiadis, P; Archavlis, E; Christidou, A; Kourtessas, D; Mantzaris, GJ; Petraki, K; Triantafyllou, G, 2001) |
| "Azathioprine is effective treatment for ulcerative colitis and Crohn's disease." | ( Fraser, AG; Jewell, DP; Orchard, TR, 2002) |
| "It describes the treatment of ulcerative colitis according to the different groups of patients and the degree of activity." | ( Nagy, F, 2002) |
| "boulardii can be effective in the treatment of ulcerative colitis." | ( Giollo, P; Guslandi, M; Testoni, PA, 2003) |
| "The standard remission maintenance treatment for ulcerative colitis (UC) is 5-amino-salicylic acid (5-ASA), given orally and topically and in different doses, with various frequencies and duration of administration." | ( Cermesoni, L; Cesana, BM; Piodi, LP; Ulivieri, FM, 2004) |
| "Guidelines for treatment of ulcerative colitis in children have been created by the working group of the Japanese Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Japanese Society for Pediatric Inflammatory Bowel Disease." | ( Tomomasa, T, 2005) |
| "Current treatment of ulcerative colitis is imperfect." | ( Fitzgerald, AJ; Ghosh, S; Mahmood, A; Melley, L; Playford, RJ, 2005) |
| "She had been diagnosed and treated for ulcerative colitis for four years." | ( Hirabayashi, K; Katayama, Y; Katsura, K; Nagao, T; Nomoto, T; Seta, T; Yokochi, M, 2006) |
| "The efficacy of various drugs used to treat ulcerative colitis (UC) was investigated." | ( El-Medany, A; El-Medany, G; Hagar, HH; Mustafa, A, 2006) |
| "Heparin could be beneficial to the treatment of active ulcerative colitis because of its anticoagulant, anti-inflammatory and immunomodulatory properties." | ( Evgenidis, N; Giouleme, O; Nikolaidis, N; Papageorgiou, A; Papaioannou, G; Patsiaoura, K; Vassiliadis, T; Zezos, P, 2006) |
| "Interestingly, treatment of ulcerative colitis with mesalazine, which displays few side effects during long-term treatment, is associated with a reduced incidence of colorectal cancer, but its molecular mechanism is not known." | ( Bos, CL; Diks, SH; Hardwick, JC; Peppelenbosch, MP; Richel, DJ; Walburg, KV, 2006) |
| "Mesalazine (5-ASA) is a standard treatment for ulcerative colitis." | ( Cap, M; Cascorbi, I; Dilger, K; Kreisel, W; Novacek, G; Remmler, C; Rössle, M; Trenk, D; Wacheck, V; Zähringer, A, 2007) |
| "Surgical treatment of ulcerative colitis is reserved for patients who fail medical therapy or who develop severe hemorrhage, perforation, or cancer." | ( Gotsch, PB; Krafczyk, MA; Langan, RC; Skillinge, DD, 2007) |
| "Maintenance treatment in ulcerative colitis should be as convenient as possible, to increase the chance of compliance." | ( Barrett, K; Joseph, R; Kamm, MA; Lees, K; Lichtenstein, GR; Sandborn, WJ; Schreiber, S, 2008) |
| "We used steroid for the treatment of ulcerative colitis and both intravenous lower molecular weight heparin and warfarin for renal vein thrombosis." | ( Hwang, YH; Jo, YJ; Jun, DW; Jung, YY; Kim, SH; Park, YS; Yang, DJ; Yu, YH, 2009) |
| "The pathogenesis and treatment of ulcerative colitis remain poorly understood." | ( Altıntas, A; Caliskan-Ak, E; Cetinel, S; Genc, Z; Isik, F; Pisiriciler, R; Sener, G; Tunali Akbay, T; Yarat, A, 2011) |
| "Optimizing treatment goals in ulcerative colitis requires recognizing the needs of patients." | ( Elkjaer, M; Marteau, P; Michetti, P; Munkholm, P; Probert, CS, 2010) |
| "The use of topical therapy in the treatment of ulcerative colitis has declined in recent years despite evidence of good efficacy." | ( Harris, MS; Lichtenstein, GR, 2011) |
| "Early diagnosis and treatment of ulcerative colitis (UC) is clinically challenging." | ( Chen, Y; Jiang, B; Kang, B; Liu, S; Lu, C; Lu, Y; Wang, H; Yang, X; Zhang, J; Zhao, X; Zhi, F, 2011) |
| "The goals of treatment for ulcerative colitis (UC) are to induce and maintain corticosteroid-free remission, thereby reducing hospitalizations and surgeries and preventing longer-term disease complications including colorectal cancer." | ( La Nauze, RJ; Sparrow, MP, 2011) |
| "A 19-year-old Japanese man had been treated for ulcerative colitis for 2 years." | ( Danno, K; Fujimoto, N; Tanaka, T; Uenishi, T; Wakabayashi, M, 2011) |
| "The bark of was used in the treatment of ulcerative colitis (UC) and colic pain traditionally hence present work was undertaken to identify the phytoconstituent responsible for this activity." | ( Ganjare, AB; Nirmal, SA; Patil, AN, 2011) |
| "It has been recommended that the treatment of active ulcerative colitis (UC) should be continued until complete healing of endoscopic lesions." | ( Colombo, E; D'Incà, R; Fasoli, R; Gullotta, R; Lombardi, G; Meucci, G; Saibeni, S; Terpin, M; Valpiani, D, 2012) |
| "We suggest that the effect of TMP treatment in ulcerative colitis may be related to PPAR-γ signaling, but is independent of PPAR-γ." | ( Chen, N; Chen, W; He, X; Lu, Y; Yang, X; Zheng, Z, 2012) |
| "Nicotine's application as a therapeutic treatment in ulcerative colitis is limited." | ( Leong, RW; Lunney, PC, 2012) |
| "Currently available drugs for the treatment of ulcerative colitis (UC) include salicylates, thiopurines, corticosteroids and new anti-tumour necrosis factor (TNF)-α biologics." | ( Akagi, M; Goishi, H; Kajihara, T; Miura, T; Sugiyama, S; Tanaka, T, 2013) |
| "Infliximab was approved for the treatment of ulcerative colitis (UC) in 2006 and has recently been used as rescue therapy in steroid-refractory UC." | ( Chae, HB; Hong, SN; Huh, KC; Jang, HJ; Jung, SA; Jung, Y; Jung, YS; Kim, JH; Kim, YH; Kim, YS; Lee, CK; Park, DI; Shin, JE; Song, HJ, 2014) |
| "The classical aim of the treatment of ulcerative colitis is to induce and maintain remission." | ( García-Sánchez, V; Iglesias-Flores, E, 2011) |
| "Azathioprine (AZA) is an established treatment for ulcerative colitis (UC)." | ( Ansari, S; Clark, T; Ford, AC; Hamlin, PJ; Sood, R, 2015) |
| "Conventional medical treatment for ulcerative colitis can have limited efficacy or severe adverse reactions requiring additional treatment or colectomy." | ( Jeen, YT; Park, SC, 2015) |
| "Mesalazine is a key drug in the treatment of ulcerative colitis (UC)." | ( Buurman, DJ; De Monchy, JG; Dijkstra, G; Kleibeuker, JH; Schellekens, RC; van der Waaij, LA, 2015) |
| "In contrast to other agents used in the treatment of ulcerative colitis, 5-ASA does not have any known anti-inflammatory effect on other organs or other colonic inflammatory diseases like diverticulitis." | ( Hauso, Ø; Martinsen, TC; Waldum, H, 2015) |
| "Physicians traditionally treat ulcerative colitis (UC) using a step-up approach." | ( Fournier, N; Rogler, G; Safroneeva, E; Schoepfer, AM; Straumann, A; Vavricka, SR, 2015) |
| "To validate its folk use in the treatment of ulcerative colitis (UC)." | ( Dhikale, RS; Girme, AS; Mandal, SC; Nirmal, SA; Pal, SC, 2015) |
| "Thiopurines are effective drugs in treating ulcerative colitis (UC) and Crohn's disease (CD) even if studies that specifically investigate these drugs' profile of efficacy in UC compared with CD are scarce." | ( Caporaso, N; Castiglione, F; De Palma, GD; Diaferia, M; Donetto, S; Maione, F; Musto, D; Nardone, O; Rispo, A; Testa, A, 2015) |
| "She was under treatment for ulcerative colitis." | ( Kanno, S; Mochizuki, H; Ogawa, R; Oikawa, T; Shibuya, S; Shijo, T, 2015) |
| "In the treatment of ulcerative colitis with mesalazine, we should pay attention with patient's cough or fever for early detection of drug-induced pneumonia." | ( Abe, T; Akiyama, N; Matsui, T; Nozue, T; Suda, T; Yokomura, K, 2015) |
| "Adalimumab was approved for the treatment of ulcerative colitis refractory to conventional therapy several years later than infliximab in Europe." | ( Bálint, A; Bor, R; Csontos, Á; Farkas, K; Gábor, Z; Hegede, G; Horváth, G; Juhász, M; Lakner, L; Miheller, P; Milassin, Á; Molnár, T; Nagy, F; Palatka, K; Rácz, I; Rutka, M; Szabó, A; Szepes, Z; Szűcs, M; Vincze, Á; Zsigmond, F; Zsóri, Á, 2016) |
| "The medical treatment of ulcerative colitis (UC) has seen a change towards a more active attitude during recent years, including both the use of more traditional drugs as well as new biological substances." | ( Holmström, T; Karlbom, U; Rönnblom, A; Sjöberg, D; Tanghöj, H; Thörn, M, 2016) |
| "Recently, several medical treatments for ulcerative colitis (UC) have been developed, including 5-aminosalicylic acids (5-ASAs), corticosteroids, thiopurine, calcineurin inhibitors, and anti-tumor necrosis factor (TNF) α treatments." | ( Kanai, T; Mizuno, S; Naganuma, M; Nanki, K; Sugimoto, S, 2016) |
| "Real-life long-term data on infliximab treatment in ulcerative colitis are limited." | ( Almer, S; Angelison, L; Bajor, A; Björk, J; Eriksson, A; Fagerberg, U; Grip, O; Halfvarson, J; Hammarlund, P; Hertervig, E; Hindorf, U; Hjortswang, H; Karling, P; Löfberg, R; Marsal, J; Thörn, M; Torp, J, 2017) |
| "Budesonide foam is used for the topical treatment of distal ulcerative colitis." | ( Aoyama, N; Hibi, T; Hirai, F; Kobayashi, K; Naganuma, M; Tada, T; Watanabe, K; Watanabe, M, 2018) |
| "Mesalamine is commonly used to treat ulcerative colitis (UC)." | ( Daly, MJ; Huang, H; Kaplan, JL; Moran, CJ; Rivas, M; Winter, HS, 2018) |
| "Consequently, new alternatives for the treatment of ulcerative colitis are constantly being sought." | ( Akobeng, AK; Baines, PA; Gordon, M; Iheozor-Ejiofor, Z; Kaur, L; Sinopoulou, V, 2020) |
| "Consequently, new alternatives for the treatment of ulcerative colitis are constantly being sought." | ( Akobeng, AK; Baines, PA; Gordon, M; Iheozor-Ejiofor, Z; Kaur, L; Sinopoulou, V, 2020) |
| "Therefore, in diagnosing and treating ulcerative colitis, noninvasive, low-cost methods for predicting mucosal healing using useful biomarkers are required in the clinical setting." | ( Chayama, K; Hayashi, R; Ito, M; Kumada, J; Naito, T; Nomura, M; Oka, S; Takigawa, H; Tanaka, S; Ueno, Y; Wakai, M, 2020) |
| "The effectiveness of plants in treating ulcerative colitis has been determined." | ( Akkol, EK; Karpuz, B; Khan, H; Sobarzo-Sánchez, E, 2020) |
| "Infliximab can improve DM in the treatment of ulcerative colitis." | ( Chen, L; Gu, GL; Han, LC; Huang, BB; Li, SQ; Liu, GF; Lv, XD; Lv, XP; Wang, HQ; Zhan, LL, 2020) |
| "Accordingly, in the treatment of ulcerative colitis, tonifying medicine, heat clearing medicine and Qi regulating medicine are often used for oral administration and heat clearing medicine, hemostatic medicine and tonifying medicine are often used for enema administration." | ( Jia, Y; Li, XM; Miao, MS; Wang, ZZ, 2021) |
| "Flurbiprofen (FLBP), used in the treatment of ulcerative colitis, has a short biological half-life." | ( Pande, S; Solanki, A; Vashi, J, 2022) |
| "The effective treatment of ulcerative colitis (UC) poses substantial challenges, and the aetiopathogenesis of UC is closely related to infectious, immunological and environmental factors." | ( Du, Y; Gu, Y; Jiang, L; Liu, J; Tang, X; Yang, M, 2021) |
| "pharnaceoides crude extract in the treatment of ulcerative colitis and might be a promising remedy to manage inflammatory disorders." | ( Arshad, HM; Aslam, N; Awan, AM; Jabeen, Q; Javaid, F; Majeed, W, 2022) |
| "Ax-Alg had better effect on the treatment of ulcerative colitis than oil-in-water emulsion, which can be attributed to the synergistic effect of Ax and alginate." | ( Ai, C; Song, S; Wu, S; Xu, Y; Zhang, C; Zheng, W, 2022) |
| "The dose and duration of mesalazine treatment for ulcerative colitis (UC) is a potentially important determinant of effectiveness, with evidence suggesting that continuing the induction dose for 6-12 months may improve outcomes; however, real-world data are lacking." | ( Bezemer, G; Bodelier, A; Bruin, K; Jansen, J; Keulen, E; Koussoulas, V; Kuijvenhoven, J; Lubbinge, H; Minderhoud, I; Ouwendijk, R; Russel, M; Tang, T; Van der Meulen, A; Van Dobbenburgh, A; Van Nistelrooy, M; Vandebosch, S; West, R; Wolters, L, 2022) |
| "Antibiotics have been considered to treat ulcerative colitis (UC) due to their antimicrobial properties against intestinal bacteria linked to inflammation." | ( Akobeng, AK; Gordon, M; Grafton-Clarke, C; Sinopoulou, V, 2022) |
| "The mechanism of Emodin in the treatment of ulcerative colitis relies on its regulation of PPARγ signal pathway, which could modulate colonic metabolism and restore intestinal homeostasis." | ( Chen, Y; Guo, S; He, J; Huang, B; Huang, S; Li, Y; Luo, S; Luo, X; Su, Y; Wang, X; Yang, G; Zhou, L, 2022) |
| "RCT studies on Vitamin D in the treatment of ulcerative colitis were searched from CNKI, Wanfang Data, PubMed, Cochrane Library, and Web of Science databases." | ( Guo, X; Huang, Y; Liu, C, 2022) |
| "XLP might treat ulcerative colitis by regulating the TLR4/MyD88/NF-κB signaling pathway." | ( Dai, Y; Ding, K; Hu, Y; Jiang, J; Li, P; Lu, Q; Zhao, M; Zhao, T; Zhu, J, 2023) |
| "Curcumin's role in the treatment of ulcerative colitis (UC) has been proven by numerous studies, but its preventive administration, with the aim of reducing the remission episodes that are characteristic of this disease, must be further investigated." | ( Hales, D; Kiss, B; Muntean, DM; Neag, MA; Porfire, A; Rațiu, IA; Sesărman, A; Ștefan, MG; Tefas, LR; Tomuță, I, 2022) |
| "Steroids are one of the main treatments for ulcerative colitis; however, steroids work well for only about 50% of people who take them." | ( Barr, A; Bedford, H; Blackwell, S; Coates, E; Dames, N; Hind, D; Lee, M; Lobo, A; Probert, C; Sebastian, S; Shackley, P; Totton, N; Wickramasekera, N, 2022) |
| "Sulfasalazine (SZ) is commonly used to treat pediatric ulcerative colitis (UC)." | ( Bousvaros, A; Chan, C; Liu, E; Mansuri, I; Rufo, PA; Wang, S, 2023) |
| "As potential candidates for treating ulcerative colitis (UC), polysaccharides have been attracting extensive interest in recent years." | ( Chen, C; Chen, S; Cui, SW; Dong, N; Fang, Q; Nie, S; Wang, J; Zhang, Y, 2023) |
| "As the first-line drug to treat ulcerative colitis (UC), long-term use of glucocorticoids (GCs) produces severe toxic and side effects." | ( Deng, SJ; Dong, K; Guan, ZL; Guo, ZY; He, BY; Leng, X; Ma, RR; Wang, DY; Xing, JF; You, CY, 2023) |
| "The clinical treatment of ulcerative colitis (UC) faces great challenges due to lifetime medication." | ( Huang, X; Liu, J; Wang, Y; Yan, X; Zhang, T, 2023) |
| "(AMP) in treating ulcerative colitis as the example, we checked the effects of AMP on tryptophan metabolites." | ( Feng, WW; Hu, P; Jiang, Z; Liu, J; Yan, X; Zeng, Y, 2023) |